Browsing by Subject "Psoriasis"
Now showing items 1-3 of 3
-
Biologics and Biosimilars as Treatment Options for Psoriasis
(Brac University, 2022-02)Psoriasis is a common chronic skin disease stemming from a systemic inflammatory disorder. It affects more than 7.5 million people in the United States and an estimated 125 million people worldwide. It is an immune-mediated ... -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
(Brac University, 2023-02)FDA has approved about 12 biologics for treating psoriasis. Among them, TNF-α inhibitors have a history of causing alopecia while used for treatment. In our study, we tried to find out the relation between alopecia and the ... -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
(Brac University, 2023-02)The objective of this study was to investigate the association between TNF-alpha inhibitors and alopecia cases in psoriasis patients reported in the Food and Drug Administration Adverse Event Reporting System (FAERS) ...